Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO)’s share price hit a new 52-week low during trading on Monday . The stock traded as low as C$1.69 and last traded at C$1.69, with a volume of 501 shares changing hands. The stock had previously closed at C$1.75.
Aptose Biosciences Stock Down 2.9 %
The stock has a market capitalization of C$25.92 million, a PE ratio of -0.16 and a beta of 1.44. The company has a current ratio of 0.78, a quick ratio of 5.41 and a debt-to-equity ratio of 14.27. The company’s 50-day moving average is C$2.14 and its 200 day moving average is C$2.88.
Aptose Biosciences (TSE:APS – Get Free Report) (NASDAQ:APTO) last issued its quarterly earnings results on Tuesday, March 26th. The biotechnology company reported C($1.96) earnings per share for the quarter, topping the consensus estimate of C($1.98) by C$0.02. As a group, analysts anticipate that Aptose Biosciences Inc. will post -0.59 EPS for the current year.
About Aptose Biosciences
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
Featured Articles
- Five stocks we like better than Aptose Biosciences
- 3 Healthcare Dividend Stocks to Buy
- 3 Technologies to Challenge NAND Flash Dominance in AI
- With Risk Tolerance, One Size Does Not Fit All
- Is Zoom Video Stock Getting Too Cheap to Pass Up?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Packaging Corporation of America: Buy The Dip
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
